Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Assets Average (2018 - 2020)

Monopar Therapeutics (MNPR) has disclosed Assets Average for 3 consecutive years, with $15.5 million as the latest value for Q3 2020.

  • Quarterly Assets Average rose 189.23% to $15.5 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $15.5 million through Sep 2020, up 189.23% year-over-year, with the annual reading at $10.3 million for FY2019, 19.83% up from the prior year.
  • Assets Average hit $15.5 million in Q3 2020 for Monopar Therapeutics, up from $12.8 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $15.5 million in Q3 2020 to a low of $5.4 million in Q3 2019.
  • Historically, Assets Average has averaged $9.4 million across 3 years, with a median of $8.8 million in 2018.
  • Biggest five-year swings in Assets Average: plummeted 34.47% in 2019 and later soared 189.23% in 2020.
  • Year by year, Assets Average stood at $7.6 million in 2018, then rose by 21.41% to $9.2 million in 2019, then soared by 67.7% to $15.5 million in 2020.
  • Business Quant data shows Assets Average for MNPR at $15.5 million in Q3 2020, $12.8 million in Q2 2020, and $13.1 million in Q1 2020.